Activity of Plasmid Replicons in CAULOBACTER CRESCENTUS : Rp4 and Cole1

Por O'Neill, Edward A., Berlinberg, Craig, Bender, Robert A.
Publicado em 1983

Erratum to: Comparison of Treatment with Sitagliptin or Sulfonylurea in Patients with Type 2 Diabetes Mellitus and Mild Renal Impairment: A Post Hoc Analysis of Clinical Trials

Por Ommen, Elizabeth S., Xu, Lei, O’Neill, Edward A., Goldstein, Barry J., Kaufman, Keith D., Engel, Samuel S.
Publicado no Diabetes Ther (2015)

Comparison of Treatment with Sitagliptin or Sulfonylurea in Patients with Type 2 Diabetes Mellitus and Mild Renal Impairment: A Post Hoc Analysis of Clinical Trials

Por Ommen, Elizabeth S., Xu, Lei, O’Neill, Edward A., Goldstein, Barry J., Kaufman, Keith D., Engel, Samuel S.
Publicado no Diabetes Ther (2015)

A Randomized, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Adding Omarigliptin to Antihyperglycemic Therapies in Japanese Patients with Type 2 Diabetes and Inadeq...

Por Gantz, Ira, Okamoto, Taro, Ito, Yuka, Sato, Asako, Okuyama, Kotoba, O’Neill, Edward A., Engel, Samuel S., Lai, Eseng
Publicado no Diabetes Ther (2017)

A randomized, placebo‐ and sitagliptin‐controlled trial of the safety and efficacy of omarigliptin, a once‐weekly dipeptidyl peptidase‐4 inhibitor, in Japanese patients with type 2...

Por Gantz, Ira, Okamoto, Taro, Ito, Yuka, Okuyama, Kotoba, O'Neill, Edward A., Kaufman, Keith D., Engel, Samuel S., Lai, Eseng
Publicado no Diabetes Obes Metab (2017)

A randomized, placebo-controlled study of the cardiovascular safety of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus

Por Gantz, Ira, Chen, Menghui, Suryawanshi, Shailaja, Ntabadde, Catherine, Shah, Sukrut, O’Neill, Edward A., Engel, Samuel S., Kaufman, Keith D., Lai, Eseng
Publicado no Cardiovasc Diabetol (2017)

Randomized clinical trial comparing the efficacy and safety of treatment with the once‐weekly dipeptidyl peptidase‐4 (DPP‐4) inhibitor omarigliptin or the once‐daily DPP‐4 inhibito...

Por Goldenberg, Ronald, Gantz, Ira, Andryuk, Paula J., O'Neill, Edward A., Kaufman, Keith D., Lai, Eseng, Wang, Yin Na, Suryawanshi, Shailaja, Engel, Samuel S.
Publicado no Diabetes Obes Metab (2017)

A randomized, placebo-controlled clinical trial evaluating the safety and efficacy of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus inadequ...

Por Lee, Seung-Hwan, Gantz, Ira, Round, Elizabeth, Latham, Melanie, O’Neill, Edward A., Ceesay, Paulette, Suryawanshi, Shailaja, Kaufman, Keith D., Engel, Samuel S., Lai, Eseng
Publicado no BMC Endocr Disord (2017)

Randomized clinical trial of the safety and efficacy of sitagliptin and metformin co‐administered to Chinese patients with type 2 diabetes mellitus

Por Ji, Linong, Han, Ping, Wang, Xiaoyue, Liu, Jingdong, Zheng, Shaoxiong, Jou, Ying‐Ming, O'Neill, Edward A, Golm, Gregory T, Engel, Samuel S, Kaufman, Keith D, Shankar, R Ravi
Publicado no J Diabetes Investig (2016)

Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control

Por Bays, Harold E, Brinton, Eliot A, Triscari, Joseph, Chen, Erluo, Maccubbin, Darbie, MacLean, Alexandra A, Gibson, Kendra L, Ruck, Rae Ann, Johnson-Levonas, Amy O, O’Neill, Edward A, Mitchel, Yale B
Publicado no Vasc Health Risk Manag (2015)

Biochemical characterization of cholesteryl ester transfer protein inhibitors

Por Ranalletta, Mollie, Bierilo, Kathleen K., Chen, Ying, Milot, Denise, Chen, Qing, Tung, Elaine, Houde, Caroline, Elowe, Nadine H., Garcia-Calvo, Margarita, Porter, Gene, Eveland, Suzanne, Frantz-Wattley, Betsy, Kavana, Mike, Addona, George, Sinclair, Peter, Sparrow, Carl, O'Neill, Edward A., Koblan, Ken S., Sitlani, Ayesha, Hubbard, Brian, Fisher, Timothy S.
Publicado em 2010